Kimura Hiroyuki, Ozaki Norio
Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ther Apher Dial. 2006 Aug;10(4):328-32. doi: 10.1111/j.1744-9987.2006.00385.x.
A high prevalence of depressive disorder, between 33% and 50%, has been reported in dialysis patients, although it is difficult to distinguish the physical symptoms like general fatigue, insomnia, and loss of appetite which are common among dialysis patients, from the psychiatric symptoms seen in depressive patients. Furthermore, co-occurrence of depression has been shown to be one of the risk factors of poor prognosis in dialysis patients, partly because depressed patients are less likely to adhere to their medication regimen and modify their lifestyle appropriately. The efficacy of psychiatric interventions, including pharmacotherapy and psychotherapy, has been examined for dialysis patients with co-occurrence of depression. Randomized controlled trials of psychiatric interventions for depression in dialysis patients are needed to investigate the impact of such interventions on depression, quality of life, and mortality.
据报道,透析患者中抑郁症的患病率很高,在33%至50%之间,尽管很难将透析患者中常见的身体症状,如全身疲劳、失眠和食欲不振,与抑郁症患者的精神症状区分开来。此外,抑郁症的共病已被证明是透析患者预后不良的危险因素之一,部分原因是抑郁症患者不太可能坚持药物治疗方案并适当改变生活方式。对于合并抑郁症的透析患者,已经研究了包括药物治疗和心理治疗在内的精神科干预措施的疗效。需要对透析患者抑郁症的精神科干预进行随机对照试验,以研究此类干预对抑郁症、生活质量和死亡率的影响。